Abstract: Sequence analysis of 49 clones derived from the plasma of patient 30-1 on day 14 revealed that 25 clones contained the
G36D mutation, while 8 contained the
V38A mutation.
Abstract: The mean 50% inhibition concentrations (IC(50)s) for mutants
G36D and
V38A (patient 30-1) were 2.3 microg/ml and 11.2 microg/ml, respectively, statistically significant increases of 9.1- and 45-fold, respectively, compared with those of wild-type
Env.